title: Mediastinal staging of non-small-cell lung cancer.
abstract: Accurate mediastinal staging is the hallmark of a sound thoracic oncology program. Mediastinal staging remains the most important validated tool for making treatment decisions for patients with non-small-cell lung cancer. The last few years have seen the emergence of several new techniques to improve mediastinal staging. This article summarizes the current state of the art of this rapidly evolving field.
authors.affiliation: Department of Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.
authors.forename: Samjot Singh
authors.initials: SS
authors.lastname: Dhillon
authors.forename: Jaspreet Kaur
authors.initials: JK
authors.lastname: Dhillon
authors.forename: Sai
authors.initials: S
authors.lastname: Yendamuri
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000556:secondary* / Q000628:therapy; D003661:Decision Support Techniques; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology* / Q000628:therapy; D008198:Lymph Nodes / Q000473:pathology*; D008207:Lymphatic Metastasis; D008482:Mediastinum; D009367:Neoplasm Staging / Q000379:methods*; D018579:Patient Selection; D011237:Predictive Value of Tests